Freedom of Choice
An open architecture allows cancer centers the freedom of choice; the freedom to choose information technology (IT), imaging, planning, and treatment delivery systems that best meet your requirements today and your plans for the future.

Centralized Oncology IT
As the leader in developing real-time, control interfaces that connect the IMPAC EMR to the devices that are integral to the therapy process – imaging devices, virtual and conventional simulators, treatment planning systems, treatment machines, as well as laboratory systems, drug dispensing systems, and hospital information systems – IMPAC oncology IT solutions allow your cancer centers to select ‘best of breed’ equipment, without worrying about connectivity to your EMR, or your IT infrastructure.

Commitment to Standardization
Because IMPAC is committed to industry standards and open system integration – we are committed to leading the development of systems and standards to effectively incorporate these technologies into the therapy process. IMPAC demonstrated this commitment by developing and distributing the treatment planning import/export specification, which, in turn, encouraged the quicker release of the DICOM RT standard. Since the release of DICOM RT, IMPAC has embraced the standard, incorporated it into our product foundation, and even expanded it to establish a new standard for device integration. IMPAC’s DICOM treatment machine interface (DTMI) is based on the DICOM protocol yet addresses the unique requirements of radiation therapy. Ongoing development of the standard is now managed by the DICOM community where IMPAC is an active participant; IMPAC also actively supports the radiation therapy goals of the Integrated Healthcare Enterprise (IHE).

Cost Effective, High Quality Care
Above all standardization benefits the customer by resulting in better pricing and easier implementation of new treatment technology. And IMPAC ensures that all new technology is easily incorporated into a comprehensive electronic chart that supports the latest advances in cancer care.